ZimVie ZIMV 深 滬
等待開盤 10-14 09:30:00 美东时间
18.97
+0.010
+0.05%
華盛通- 最 高18.99
- 今 開18.96
- 成交量 27.85万股
- 最 低 18.96
- 昨 收 18.96
- 總市值 5.35亿
- 52周最高 19.01
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 8.15
- 委 比 89.71%
- 總股本 2821.07万
- 歷史最高 33.44
- 量 比 1.11
- 振 幅 0.16%
- 歷史最低 5.05
- 每 手 1
- 風險率 3.60%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ZimVie Stockholders Approve Acquisition By ARCHIMED Affiliate; Merger Expected To Close On October 20
ZimVie Inc. ("ZimVie") (NASDAQ:ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of
10-10 21:17
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
ZimVie Inc. shareholders have approved the acquisition of ZimVie by an affiliate of ARCHIMED, with the merger expected to close on October 20, 2025, subject to conditions in the Merger Agreement. ZimVie, a global leader in the dental implant market, develops and manufactures products for tooth replacement and restoration. ARCHIMED, a leading healthcare investment firm managing €8 billion, focuses on advancing healthcare businesses globally. The m...
10-10 13:15
ZimVie Inc Faces Legal Challenges Over Merger
An update from ZimVie Inc ( ($ZIMV) ) is now available. ZimVie Inc. announced a...
10-04 04:59
Insights into ZimVie's Upcoming Earnings
ZimVie (NASDAQ:ZIMV) is preparing to release its quarterly earnings on Wednesda...
07-30 04:02
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025
ZimVie Inc. announced it will report second quarter 2025 financial results and file its 10-Q on July 30, 2025. The company also revealed it will be acquired by ARCHIMED for $19.00 per share, with the transaction expected to close by year-end 2025. Upon completion, ZimVie will become a private company and its shares will no longer trade on NASDAQ. The company is withdrawing its fiscal 2025 guidance.
07-25 12:00
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China
ZimVie Inc. and Osstem Implant Co., Ltd. have formed a strategic partnership to expand ZimVie's presence in the growing Chinese dental implant market. Osstem, a leading implant provider in China with a strong distribution network, will exclusively distribute ZimVie's implant systems, enhancing product access for customers. The collaboration leverages Osstem's established market presence and ZimVie's innovative implant solutions, aiming to increas...
07-23 20:05
美股大行评级 | 丰业银行上调Meta目标价从525美元升至675美元；恩智浦获"超配"评级，目标价从190美元升至220美元
今日重点评级关注：瑞杰金融：维持Antero Resources Corp."强烈买入"评级，目标价从57美元升至58美元；美银证券：维持和黄医药"买入"评级，目标价从27美元升至28美元
07-23 09:42
美股牛股 | ZIMV飙涨超120%，公司获高额溢价收购；“Meme股”OpenDoor续涨超42%
ZIMV飙涨超120%，公司获高额溢价收购；散户持续爆炒，“Meme股”OpenDoor续涨超42%；英伟达合作商纳微半导体大涨超24%>>
07-22 19:50
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, ZIMV, XAGE on Behalf of Shareholders
NEW YORK, July 21, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
07-22 00:44
ZimVie Stock (ZIMV) Rockets 120% on ARCHIMED Deal
ZimVie stock rallied on Monday after it announced an acquisition deal with ARCH...
07-21 21:23
